Mabsoft Therapeutics (Shanghai) Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: Ia Study of MST-931 in Healthy Adult Subjects Recruitment opened
- Minor: MST-168 · Advanced Solid Malignant Tumors Start date changed from estimate of Nov 15, 2026 to Oct 26, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-29 | NCT07903493 Phase Ia Study of MST-931 in Healthy Adult Subjects | Phase 1 | Recruiting |
Active trials by phase
| Phase 1 | 2 |
Disease areas by active trials
Get alerts when Mabsoft Therapeutics (Shanghai) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.